2-29349433-A-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_004304.5(ALK):​c.1283-20952T>C variant causes a intron change. The variant allele was found at a frequency of 0.365 in 152,086 control chromosomes in the GnomAD database, including 10,479 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 10479 hom., cov: 32)

Consequence

ALK
NM_004304.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 4.11

Publications

7 publications found
Variant links:
Genes affected
ALK (HGNC:427): (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
ALK Gene-Disease associations (from GenCC):
  • neuroblastoma, susceptibility to, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.23).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.518 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALKNM_004304.5 linkc.1283-20952T>C intron_variant Intron 5 of 28 ENST00000389048.8 NP_004295.2 Q9UM73B6D4Y2
ALKXR_001738688.3 linkn.2210-20952T>C intron_variant Intron 5 of 17
LOC101929386XR_007086263.1 linkn.448-2027A>G intron_variant Intron 3 of 4
LOC101929386XR_939920.3 linkn.851-731A>G intron_variant Intron 7 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALKENST00000389048.8 linkc.1283-20952T>C intron_variant Intron 5 of 28 1 NM_004304.5 ENSP00000373700.3 Q9UM73
ALKENST00000618119.4 linkc.152-20952T>C intron_variant Intron 4 of 27 5 ENSP00000482733.1 A0A087WZL3
ENSG00000286963ENST00000655343.1 linkn.292-2027A>G intron_variant Intron 3 of 4
ENSG00000286963ENST00000731703.1 linkn.381-2027A>G intron_variant Intron 4 of 6

Frequencies

GnomAD3 genomes
AF:
0.364
AC:
55368
AN:
151968
Hom.:
10448
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.284
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.384
Gnomad ASJ
AF:
0.416
Gnomad EAS
AF:
0.230
Gnomad SAS
AF:
0.533
Gnomad FIN
AF:
0.379
Gnomad MID
AF:
0.396
Gnomad NFE
AF:
0.400
Gnomad OTH
AF:
0.386
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.365
AC:
55450
AN:
152086
Hom.:
10479
Cov.:
32
AF XY:
0.366
AC XY:
27224
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.285
AC:
11809
AN:
41474
American (AMR)
AF:
0.385
AC:
5877
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.416
AC:
1441
AN:
3468
East Asian (EAS)
AF:
0.231
AC:
1194
AN:
5170
South Asian (SAS)
AF:
0.535
AC:
2580
AN:
4822
European-Finnish (FIN)
AF:
0.379
AC:
4003
AN:
10574
Middle Eastern (MID)
AF:
0.408
AC:
120
AN:
294
European-Non Finnish (NFE)
AF:
0.400
AC:
27222
AN:
67988
Other (OTH)
AF:
0.384
AC:
810
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1810
3620
5431
7241
9051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
556
1112
1668
2224
2780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.381
Hom.:
14712
Bravo
AF:
0.356
Asia WGS
AF:
0.400
AC:
1390
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.23
CADD
Benign
20
DANN
Benign
0.69
PhyloP100
4.1
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12996631; hg19: chr2-29572299; API